QA: Oncotelic Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000908259_2020_Oncotelic_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000908259, Oncotelic Therapeutics Inc

  xvar xval
0 AssetsCurrent 273,000
1 IntangibleAssetsNetIncludingGoodwill 21,987,027
2 PropertyPlantAndEquipmentNet 47,554
3 remainder_Assets 1,377,200
4 LiabilitiesCurrent 6,783,106
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,838,558
9 ResearchAndDevelopmentExpense 1,301,970
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,336,022
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,684,781
1 Liabilities 6,783,106
2 Expenses 4,140,528
3 Revenues 0
4 StockholdersEquity 16,901,675
5 NetIncome -5,476,550
6 ComprehensiveNetIncome -5,476,550
7 BaseVar 17,972,218
8 EconomicCapitalRatiobeforeLimitedLiability 2.06
9 EconomicCapitalRatio 3.06

Edgar->Model Mapping

Feature Distribution

Change over Time